Suppr超能文献

澳大利亚人在使用尼古丁电子烟产品戒烟时是否会通过处方途径?

Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?

机构信息

School of Psychological Sciences, The University of Melbourne, Australia; NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, Australia; School of Psychology, Deakin University, Geelong, Australia.

School of Psychological Sciences, The University of Melbourne, Australia; NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, Australia.

出版信息

Int J Drug Policy. 2024 Jun;128:104460. doi: 10.1016/j.drugpo.2024.104460. Epub 2024 May 21.

Abstract

BACKGROUND

In Australia, nicotine vaping products (NVPs) are only legally available to those with a prescription from a doctor. We investigated the proportion of people using NVPs to quit smoking who had a prescription, and whether this increased following regulatory changes in 2021 that strengthened the prescription requirement.

METHODS

Australian data from the 2018, 2020 and 2022 International Tobacco Control (ITC) Project Survey were analysed using GEE models with Poisson regressions to analyze differences between years. Data from participants who reported making a quit attempt in the previous two years and reported use of NVPs on their last quit attempt were included (480 observations across 418 individuals). Participants reported whether they had a prescription for NVPs on their last quit attempt. In 2022, they were also asked whether they sourced their prescription from their usual medical practice.

RESULTS

Among those using NVPs for a quit attempt, use with a prescription increased significantly from 2020 to 2022 (IRR = 0.35 (0.17-0.73), p = .005) but was still low at 16.5 % (95 % CI 11.4-23.1). In 2022, among the small number who reported getting a prescription for NVPs, 27 % reported getting it from their regular practice; the remainder from a specialist online doctor service.

CONCLUSION

There was a modest increase in obtaining a prescription among those who used NVPs for their last quit attempt after regulations were strengthened, however most NVP use for quitting was without a prescription.

摘要

背景

在澳大利亚,尼古丁电子烟产品(NVPs)仅在获得医生处方的情况下才能合法购买。我们调查了使用 NVPs 戒烟的人中,有多少人有处方,以及在 2021 年加强处方要求的监管改革后,这一比例是否有所增加。

方法

使用广义估计方程(GEE)模型和泊松回归分析 2018 年、2020 年和 2022 年澳大利亚国际烟草控制(ITC)项目调查的数据,以分析各年之间的差异。数据分析包括在过去两年内报告有戒烟尝试且在上一次戒烟尝试中使用过 NVPs 的参与者(418 名参与者中的 480 个观察值)。参与者报告他们在上一次戒烟尝试中是否有 NVPs 的处方。在 2022 年,他们还被问及他们的处方是否来自他们的常规医疗实践。

结果

在使用 NVPs 戒烟的人群中,使用处方的比例从 2020 年到 2022 年显著增加(IRR = 0.35(0.17-0.73),p =.005),但仍较低,为 16.5%(95%CI 11.4-23.1)。在 2022 年,在报告获得 NVPs 处方的少数人中,27%的人从常规实践中获得处方;其余的则从专门的在线医生服务处获得。

结论

在加强监管后,使用 NVPs 进行最后一次戒烟尝试的人中,获得处方的人数略有增加,但大多数 NVPs 用于戒烟的处方是没有处方的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/784a/11337190/745bfd3152c0/nihms-1998570-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验